Back
Splash Beverage Group Vs. Keros Therapeutics Industry Stock Comparison
Sell
9
SBEV
Splash Beverage Group
Last Price:
$3.50
Seasonality Move:
176.69%
Sell
20
KROS
Keros Therapeutics
Last Price:
$13.79
Seasonality Move:
0.65%
Sell
9
Splash Beverage Group (SBEV)
is a Sell
Is Splash Beverage Group a Buy, Sell or Hold?
-
The current Splash Beverage Group [SBEV] share price is $3.69. The Score for SBEV is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
SBEV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $13.75. The Score for KROS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
SBEV Stock Price Chart
What is Splash Beverage Group's stock price today?
-
The Splash Beverage Group share price today is $3.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SBEV is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $13.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
SBEV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 40.8 | Sell |
Chaikin Money Flow: | 11260 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.57 - 5.45) | Sell |
Bollinger Bands (100): | (2.97 - 7.47) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 44.91 | Sell |
Chaikin Money Flow: | -51799 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.73 - 14.65) | Sell |
Bollinger Bands (100): | (10.65 - 13.91) | Buy |
SBEV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.76 | Sell |
20-day SMA: | 4.17 | Sell |
50-day SMA: | 4.3 | Sell |
200-day SMA: | 7.19 | Sell |
8-day EMA: | 3.78 | Sell |
20-day EMA: | 4.14 | Sell |
50-day EMA: | 4.54 | Sell |
200-day EMA: | 7.58 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.57 | Sell |
20-day SMA: | 14.29 | Sell |
50-day SMA: | 13.41 | Buy |
200-day SMA: | 30.5 | Sell |
8-day EMA: | 14.41 | Sell |
20-day EMA: | 14.3 | Sell |
50-day EMA: | 14.01 | Sell |
200-day EMA: | 25.22 | Sell |
Splash Beverage Group Earnings Growth & SBEV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.60 per share, and a decrease next year of $0.80 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.
Splash Beverage Group Technical Analysis
May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |